Antiviral Activity of Ailanthone from Ailanthus altissima on the Rice Stripe Virus

Viruses. 2023 Dec 31;16(1):73. doi: 10.3390/v16010073.

Abstract

Rice stripe disease caused by the rice stripe virus (RSV), which infects many Poaceae species in nature, is one of the most devastating plant viruses in rice that causes enormous losses in production. Ailanthone is one of the typical C20 quassinoids synthesized by the secondary metabolism of Ailanthus altissima, which has been proven to be a biologically active natural product with promising prospects and great potential for use as a lead structure for pesticide development. Based on the achievement of the systemic infection and replication of RSV in Nicotiana benthamiana plants and rice protoplasts, the antiviral properties of Ailanthone were investigated by determining its effects on viral-coding RNA gene expression using reverse transcription polymerase chain reaction, and Western blot analysis. Ailanthone exhibited a dose-dependent inhibitory effect on RSV NSvc3 expression in the assay in both virus-infected tobacco plants and rice protoplasts. Further efforts revealed a potent inhibitory effect of Ailanthone on the expression of seven RSV protein-encoding genes, among which NS3, NSvc3, NS4, and NSvc4 are the most affected genes. These facts promoted an extended and greater depth of understanding of the antiviral nature of Ailanthone against plant viruses, in addition to the limited knowledge of its anti-tobacco mosaic virus properties. Moreover, the leaf disc method introduced and developed in the study for the detection of the antiviral activity of Ailanthone facilitates an available and convenient screening method for anti-RSV natural products or synthetic chemicals.

Keywords: ailanthone; coat protein; in vivo antiviral; movement protein; quassinoid; rice stripe virus.

MeSH terms

  • Ailanthus*
  • Antiviral Agents / pharmacology
  • Biological Products*
  • Nicotiana
  • Quassins*
  • Tenuivirus* / genetics

Substances

  • ailanthone
  • Quassins
  • Biological Products
  • Antiviral Agents

Grants and funding

This research was funded by the National Natural Science Foundation of China (grant number 31972317), the Provincial Natural Science Foundation of Fujian (grant number 2021J01067), and The Foundation of The Engineering Technology Research Center of Characteristic Medicinal Plants of Fujian, Ningde Normal University (grant number PP202103).